Tweetovi

Blokirali ste korisnika/cu @InnDeptInvestor

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @InnDeptInvestor

  1. Prikvačeni tweet
    13. sij

    Week, well positioned 2020. Big3 : now in clinic (or doorsteps): analysts upgr+acquisitions. , tiny hugely progressed clinicals, tiny BIG chance on taking 20% $$$ of

    Poništi
  2. Big trading ahead for If analysts see good value and applied stock could see highs breaking out recent range to above $19s, otherwise treading water for sometime...

    Poništi
  3. Reminds selling all time bottom, 25% up since the sale. is THE buy now, quick recovery back into $60-70 w@@th

    Poništi
  4. 4. velj

    downgrade was actually a BUY call, big gains short term as more trial data is highly expected. not sure who is still selling, this has been heavily bought by , quite a few visiting fund manager guests.

    Poništi
  5. 3. velj

    Who downgrades at this time in the game?! Only This is a Strong But here in $50s $90-100 when taken over @

    Poništi
  6. 3. velj

    is 0% impacted & benefiting on coronavirus healthy stay-in food demand. Screaming recovery into mid $9s & $12-14 range. still very probable takeover/taking minority stake2protect supply chain, we saw empty produce shelves on a recent supplier exit

    Poništi
  7. 3. velj

    Expecting huge recovery on oversold beaten down best in class and most promising Will only get higher from here if coronavirus stays relatively contained in US and outside China. and small plays in , data expected

    Poništi
  8. 31. sij

    On the opposite side of trade @ . Added below $52, recent stake reductions are purely short term cash needs. Expecting new set of trial data, big news of 1st patient dosing will HUGE Pop! Don't mix coronavirus, just use as opportunity. PT $75+

    Poništi
  9. 31. sij

    revs and earnings are breaking out as well. Considering below $2s as decent entry point here, adding...

    Poništi
  10. 31. sij

    Important week close for , picking @ high $2s on advanced new testing, while up 250% from recent months lows, still way below past years lows trading range $3 to $5. Seems a good opportunity now. PT $4.50-$6 although recovered, but still way below IPO mid $10s PT $12-14

    Poništi
  11. 31. sij

    decision in the presidential election that begins in Iowa on Monday!! Hopefully this nonsense ends today, and gets to work in so many real issues.

    Prikaži ovu nit
    Poništi
  12. 31. sij

    simply for actions that are inappropriate. The question then is not whether the president did it, but whether the United States Senate or the American people should decide what to do about what he did. I believe that the Constitution provides that the people should make that

    Prikaži ovu nit
    Poništi
  13. 31. sij

    investigation. When elected officials inappropriately interfere with such investigations it undermines the principle of equal justice under the law. But the Constitution does not give the Senate the power to remove the president from office and ban him from this year's ballot

    Prikaži ovu nit
    Poništi
  14. 31. sij

    making history, describes resolution of in short 2 paragraphs! "It was inappropriate for the president to ask a foreign leader to investigate his political opponent and to withhold United States aid to encourage that

    Prikaži ovu nit
    Poništi
  15. 30. sij
    Poništi
  16. 30. sij

    cuts STAKE! Nice to get some appreciated cash, when your move is real 'GMO' disaster. All 3 big names are hugely oversold, should only happen on hiccups, straight line never expected & priced in. craves new data boost!

    Poništi
  17. 27. sij

    to quickly rebound into mid $9s, earnings to drive the direction from here $12-14

    Poništi
  18. 27. sij

    Read this if consider selling on Monday as market seem to follow the epidemic. While are increasing, they just were not able to diagnose cases from weeks ago, so is the sudden spike

    Poništi
  19. 24. sij

    has to play well into , healthy food & grocery sales will only GROW. This back to $12 short term, completely oversold. Still believe 2consider taking it over, crazy not too at this valuation and the fact they expanded into conventional and geographically

    Poništi
  20. 23. sij

    While quiet, what a time to own & BUY MORE some , holding onto . This will get hot on clinical initiations and preliminary follow-ups. Huge in terms of applications, big pharma is jealously watching for the right time to STEP in

    Poništi
  21. 23. sij

    Why and treading waters... Most promising steps into the clinic, has to be best time to own both: way of the highs and not too too early in terms of trials and expected initial outcomes. off the highs, priced for 60-90% takeover premium

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·